GlassScriptPhysician profile
Ali Banaie
NPI 1386613206
$6,276.49
in general payments reported to CMS, 2019-2025
24 companies · $2,048 in 2025
The $2,048 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $698 · 2021: $710 · 2022: $843 · 2023: $915 · 2024: $492 · 2025: $2,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,956 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,956.30 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,533.98 | 2019-2025 | Rinvoq, Skyrizi, Creon |
| Olympus Medical Systems Corporation | $1,500.00 | 2025 | Evis Exera III Duodenovideoscope |
| Boston Scientific Corporation | $1,045.58 | 2020-2024 | Compliance Endokit, Autocap Rx, Orcapod |
| Janssen Biotech, INC. | $248.72 | 2020-2024 | Stelara, Simponi Aria, Simponi |
| Nestle Healthcare Nutrition INC. | $245.69 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $242.93 | 2019-2023 | Entyvio |
| Ambu INC. | $198.50 | 2020-2022 | |
| Allergan, INC. | $191.15 | 2019-2020 | |
| Olympus America INC. | $176.79 | 2022-2025 | Endoclot Sis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.57 | 2019-2025 | Xifaxan |
| Pfizer INC. | $109.39 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $108.83 | 2019-2022 | |
| Daiichi Sankyo INC. | $94.24 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $78.23 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $73.69 | 2024-2025 | Zenpep |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $69.90 | 2025 | Endoflip, Manoscan |
| Regeneron Healthcare Solutions, INC. | $55.74 | 2023-2025 | Dupixent |
| Celltrion USA INC. | $37.89 | 2025 | Vegzelma |
| Ironwood Pharmaceuticals, INC | $26.51 | 2019 | |
| Amgen INC. | $25.67 | 2021 | |
| Shionogi INC | $25.37 | 2019 | |
| Intra-Sana Laboratories | $22.43 | 2021 | |
| Getinge USA Sales, LLC | $21.08 | 2025 | Cardiohelp |
| Phathom Pharmaceuticals, INC. | $19.61 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Banaie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.